Research Corporation Technologies

• Pichia Classic Expression Platform
• Pichia GlyoSwitch™ Protein Expression System
• Ultrasound Tissue Harmonic Imaging
• VIMPAT® (lacosamide) for Treatment of Epileptic Seizures
• Creating partnerships to change medicine Partnering with entrepreneurs, founders, innovators and inventors to drive forward success

Creating partnerships to change medicine

Partnering with entrepreneurs, founders, innovators and inventors to drive forward success

• Developing tomorrow's biotechnology and medical device innovation Translating next generation life science inventions from concepts to patents, then patents to commercial products

Developing tomorrow's biotechnology and medical device innovation

Translating next generation life science inventions from concepts to patents, then patents to commercial products

• AdvaMed 2015 hosts MedTech Innovator Competition AdvaMed and RCT announce that the 2015 finals of the MedTech Innovator competition will take place at AdvaMed 2015

AdvaMed 2015 hosts MedTech Innovator Competition

AdvaMed and RCT announce that the 2015 finals of the MedTech Innovator competition will take place at AdvaMed 2015

• Licensing breakthrough technologies in the life sciences RCT licenses new, promising biomedical technologies and products to industry

Licensing breakthrough technologies in the life sciences

RCT licenses new, promising biomedical technologies and products to industry

Offering biomedical innovators the experience, expertise, and funding required for success

Through the RCT Ventures program, venture capital is provided to start-up or early-stage companies with technologies that have the potential to become significant biomedical products with a definite competitive edge Learn more › RCT develops and invests in technologies that enhance and enable the discovery and manufacture of therapeutics and diagnostics Many of these life science tools are available from RCT through affordable nonexclusive licensing Learn more ›

Biolog Expands Series A Financing, Acquires MIDI Labs

HAYWARD, Calif , Jan 04, 2023 (GLOBE NEWSWIRE) — Biolog, Inc , a leading provider of cell-based microbial identification and phenotypic profiling products, today announced the acquisition of MIDI Labs and MIDI, Inc , both headquartered in Newark, Delaware Biolog and MIDI serve … Learn more ›